S2427: Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)

Title
Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)
Principal Investigator
Fareed, Muhammad
Phase
II (Cancer Control)
Age Group
Adult
Applicable Disease Sites
Genitourinary Cancers
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Email:
Jill Stone, LPN
Research Specialist
Phone: +1 304-634-4417
Email:

View on ClinicalTrials.gov